Page 31 - Kaplan Fox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud at Clover Health Investments Corp. Kaplan Fox & Kilsheimer LLP NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com) is investigating claims on behalf of investors of Clover Health Investments Corp. (“Clover” or the “Company”) (NASDAQ: CLOV). On February 4, 2021, Hindenburg Research published a report about Clover entitled "Clover Health: How the "King of SPACs" Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation." The report claims...

Share this article Share this article NEW YORK, Jan. 29, 2021 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors who purchased AstraZeneca PLC's American Depositary Shares ("ADSs") (NASDAQ: AZN) between May 21, 2020 and November 20, 2020 (the "Class Period"). A complaint has been filed alleging that Defendants misrepresented and failed to disclose widespread flaws in the design and execution of AstraZeneca's clinical trials of its COVID-19 vaccine candidate (AZD1222), including that a substantial number of trial participants receiv...

/PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or the "Company")...

Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Boston Scientific Corporation Securities News provided by Share this article Share this article NEW YORK, Jan. 25, 2021 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a class action suit in the United States District Court for the District of Massachusetts against Boston Scientific Corporation ("Boston Scientific" or "BSX" or the "Company") (NYSE: BSX) and certain of its executives. The Complaint alleges that Defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act ...

Share this article Share this article NEW YORK, Jan. 21, 2021 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GTT Communications, Inc. ("GTT" or the "Company") (NYSE: GTT).  A complaint has been filed on behalf of investors who purchased GTT's publicly traded securities between May 5, 2016 and November 9, 2020 (the "Class Period"). According to the complaint, throughout the Class Period, GTT stated that its internal controls over financial reporting were "effective" and provided "reasonable assurance" that all required inform...